Toxic Inhalants

Published on 22/03/2015 by admin

Filed under Critical Care Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1963 times

187 Toxic Inhalants

Toxic inhalants include chemicals used for many reasons in many settings. They differ in structure and produce their effects through various mechanisms. People can be exposed to inhalational toxins in many places, including at home, at work, or in the setting of an industrial accident or terrorist event. This chapter will focus on pulmonary irritants and asphyxiants, but people can be exposed to many other types of inhalants at work.

Many inhalants cause intoxication. Tetrahydrocannabinol is the active ingredient in marijuana and is responsible for hallucinatory effects. Crack cocaine causes a sympathomimetic toxidrome as well as (rarely) hemorrhagic alveolitis. Intoxication from lysergic acid diethylamide (LSD) or phencyclidine (PCP) results in tachycardia, agitation, and hallucinations. Solvents containing hydrocarbons are commonly abused via inhalation. They include paints, glues, hair sprays, deodorants, air fresheners, and lacquers. While patients typically present in an intoxicated state, rarely they can sustain a cardiac arrest. Toluene is a commonly abused solvent. In addition to causing intoxication, users develop metabolic acidosis, severe hypokalemia, and weakness as a result of the hypokalemia.

Exposures to inhalants occur at work. Metalworkers encounter metallic fumes. Zinc oxide and cadmium both cause metal fume fever. Symptoms include fever, fatigue, and shortness of breath. Pulmonary edema from cadmium-containing fumes is very rare. Exterminators are exposed to fumigants including organophosphates and pyrethrins. Organophosphates cause a cholinergic toxidrome that includes bronchorrhea, bronchospasm, and bradycardia. Pyrethrins are associated with allergic reactions and cause symptoms of central nervous system (CNS) dysfunction only at very high doses. Workers in the semiconductor industry are exposed to inorganic hydrides, notably arsine and phosphine. In the past, dry cleaning personnel were exposed to hepatotoxins such as carbon tetrachloride and tetrachloroethylene.

image Pulmonary Irritants

The respiratory tract has several anatomic features that prevent injury. Particulates approximately 30 µM in size are trapped on the surface of the nasal turbinates.1 Nasal hairs filter larger particles, but smaller ones are inhaled into deeper parts of the respiratory tract. The airway surface liquid (ASL) is a thick mucous film that traps particles.1 As the airway branches into smaller-diameter bronchioles, particles adhere to the respiratory mucosa, further limiting access to the lower respiratory tract. Together, the cilia and ASL form the mucociliary escalator that is responsible for carrying inhaled toxins towards the more proximal airways where they are expelled. Sensory receptors in the upper airways cause a reflexive cough to assist with expulsion.2

The extent of injury is determined by the characteristics of the particle and exposure setting. These include particle size, density, shape, duration of exposure, concentration of the inhalant, and water solubility. Particles 0.5 to 3 µM in size are deposited in the distal airways and alveoli.3 However, smaller particulates are exhaled because they behave like a gas.3 Inadequate ventilation in confined spaces may lead to higher concentrations of the toxin and more severe injury when exposure occurs.

The irritant’s water solubility (Table 187-1) is the primary characteristic that affects the type of injury and likelihood for acute lung injury (ALI). Very hydrophilic (water-soluble) irritants dissolve in the water of the mucosal secretions of the nose and upper airways. Symptoms are unpleasant and occur within seconds. Victims generally escape the exposure, thereby minimizing the risk for injury. Conversely, inability to escape may result in severe injury. Less hydrophilic (i.e., more lipophilic) irritants penetrate deeper into the respiratory tract, injuring the lower airways while sparing the upper airways. As a consequence, victims typically do not experience immediate symptoms and therefore remain in the contaminated area longer, resulting in a more severe injury.45 Damage to the upper and lower airway occurs in prolonged exposures independent of the agent’s degree of water solubility.5 The mechanisms by which irritants damage the respiratory tract vary but include the direct effect of the irritant plus the inflammatory response generated from neutrophils and cytokines. Signs and symptoms include cough, sore throat, dyspnea, chest pain, wheezing, hypoxia, and rales. Rarely, patients have burns involving the skin and eyes.

TABLE 187-1 Pulmonary Irritants Arranged According to Water Solubility

High Solubility Intermediate Low Solubility
Ammonia Chlorine Phosgene
Chloramines Hydrogen sulfide Nitrogen oxides
Hydrochloric acid   Ozone
Hydrofluoric acid    
Sulfur dioxide/sulfuric acid    

General Care

Most patients exposed to chemicals present with only inhalational injuries, so care should initially focus on airway support and breathing. Bronchodilators are used to treat airway hyperreactivity.67 Endotracheal intubation is sometimes indicated to prevent collapse of the upper airway due to edema7 or to treat hypoxia. White et al. recommend that a relatively large endotracheal tube be used to intubate patients exposed to highly water-soluble agents to prevent obstruction of the endotracheal tube from mucosal sloughing.8 If arterial blood gases (ABGs) provide evidence for an acid-base disorder, the median hospital length of stay is longer.9

Chemical burns account for only a small percentage of admitted burn patients.7,10 However, patients with large dermal exposures in addition to the inhalational injury may have significant burns. In these situations, contaminated clothing should be removed and the wounds irrigated.6710 Ammonia can cause injuries to the skin that result in intraepidermal blisters and necrosis of the dermis, leading to full-thickness tissue loss.11

More commonly, patients have ocular injuries. Irritation to the eyes should be treated with copious irrigation. Irrigation may cause additional irritation to the eyes, resulting in confusion as to whether the irritation is due to the irrigation or to remaining irritants. Ocular pH testing can clarify whether additional irrigation is indicated. Irrigation should be continued until the ocular pH is neutral (7.4).6 The pH strip on a urine dipstick is a readily available way to assess ocular pH. Cycloplegics should be used to decrease pain and prevent morbidity from synechiae.7 If concern for ocular injury persists, a full examination should be done in consultation with an ophthalmologist.8

Corticosteroids

Only limited literature exists concerning the value of corticosteroids for adjuvant treatment of inhalant-induced ALI, so consensus and evidence-based recommendations do not exist. Data from animal studies suggest corticosteroids may be beneficial for the treatment of inhalant-induced ALI, but additional research is needed. In a blinded randomized controlled trial of rats exposed to ammonia, corticosteroids were not better than placebo.12

Chester et al.13 published a case report which described two sisters who were simultaneously exposed to chlorine. Both were treated in an emergency department (ED). One of the sisters was admitted to a hospital and treated for 4 days with a corticosteroid. The other sister was discharged from the ED and did not receive therapy with corticosteroids. At follow-up a year later, the sibling who received corticosteroids had a forced expiratory volume in one second (FEV1) in the normal range, whereas her sister had an FEV1 of only 80% to 85% of the predicted value.13 Multiple authors have discussed using corticosteroids in the treatment of patients with ALI from toxic inhalants,9,1418 and one review discouraged the use of these agents because of concerns about unspecified adverse effects.8

No randomized controlled trials have investigated corticosteroid treatment of ALI from direct pulmonary inhalants, but there are randomized trials studying the use of corticosteroids for treatment of ALI resulting from all causes.1920 A randomized controlled trial by the Acute Respiratory Distress Syndrome (ARDS) Network enrolled 180 patients, including 110 with ALI from direct lung injury.20 For the most part, these 110 patients had pneumonia and/or aspiration pneumonitis. The number of patients with ALI due to a toxic inhalation was not specified, so it is unclear whether the results of this trial can be generalized to patients with ALI from a toxic inhalation. Another trial also suffered from a similar limitation.19

image Specific Examples

High Water Solubility

Ammonia and Chloramines

Anhydrous ammonia [ammonia (NH3)] is a colorless gas that is lighter than air at room temperature. It has a very pungent odor which can be detected when the concentration of the gas is ≥5 parts per million (ppm).21 Anhydrous ammonia is the third most abundantly produced chemical in the world, and it has many household and industrial uses.21 Ammonia was first isolated in its pure gaseous form in 1790, and the first suspected inhalational poisoning was reported in 1841.7 Ammonia is transported under pressure as a liquid, and it can cause a hypothermic injury when it is decompressed to normal atmospheric pressure. Ammonia is used as a fertilizer, an explosive, and a chemical weapon.21 It is also used in the production of paper and pulp, in the refrigeration and petroleum industry, and in the production of dyes, plastics, and fibers.8,16 Accidents and exposures involving ammonia are increasingly common, as this substance is a key intermediate in the illicit production of methamphetamine.11

Because of its high water solubility, clinical manifestations of exposure to ammonia gas present immediately. People generally escape the exposure before becoming symptomatic, as the odor threshold of approximately 5 to 50 ppm is much lower than the irritant threshold of 400 ppm.10,22 However, ammonia is associated with olfactory fatigue,21 so people may believe they have removed themselves from an exposure when they have not. Ocular injuries are associated with exposures to concentrations ≥700 ppm. Exposures to concentrations between 2500 and 4500 ppm can lead to death within 30 minutes, largely due to airway obstruction.8,21 Concentrations of ammonia ≥5000 ppm are rapidly fatal.7,10,22

The extent of injury depends upon the duration of exposure, depth of inhalation, gas concentration, and pH of the gas.11,23 Interestingly, anhydrous ammonia itself is not caustic.24 When it dissolves in water, such as in the mucous membranes, it forms ammonium hydroxide (NH4OH), a strong base.11,21 The dissociation of ammonium hydroxide into hydroxyl ions (see below) also damages tissues and causes liquefaction necrosis.7,10

Ammonium hydroxide formation and its dissociation:

NH3 + H2O ↔ NH4OH ↔ NH4OH → NH4+ + OH

Injury to the mucosa leads to sloughing of the mucosal barrier, formation of cellular debris, edema, hemorrhage, and smooth-muscle contraction. Collectively, these effects of ammonia toxicity can precipitate airway obstruction. In one case report, injury after a massive exposure was so severe the patient required bilateral lung transplantation.10

Injuries occur first to the eyes, oropharynx, and upper respiratory tract, owing to ammonia’s high water solubility. After prolonged exposure to ammonia or after exposure to a high concentration of the gas, the lower respiratory tract is also injured.24 Ocular injuries (or their sequelae) include conjunctivitis, ulceration, iritis, cataract formation, blepharospasm, and glaucoma. Ammonia also causes hypoxia when it displaces oxygen in the lower respiratory tract.

Chloramines (see below) are nitrogenous chlorinated compounds. They are very irritating gasses produced when household bleach reacts with ammonia. Symptoms due to exposure to chloramines are typically very mild and occur very quickly, allowing potential victims to escape. However, if there is prolonged exposure or exposure to a high concentration of the gas, the patient can have injuries typical of any highly water-soluble irritant.

Chloramine production:

3 NaOCl + 2 NH3 ↔ NH2Cl + NHCl2 + 3 NaOH. B, NH2Cl + H2O ↔ HOCl + NH3

Intermediate Water Solubility

Chlorine

Chlorine is a green-yellow gas with a very pungent odor that is twice as dense as air. It was discovered in the 1770s and soon became useful as a commercial agent.1718 Its odor can be detected at concentrations as low as 0.2 ppm.18 Its intermediate solubility in water promotes damage at all levels of the respiratory tract.25 Exposures to chlorine concentrations greater than 430 ppm have resulted in death.17 Chlorine causes cellular injury by the generation of oxygen free radicals and oxidation of functional groups in cellular components.9

Chlorine has many uses. France and Germany used it as a chemical warfare agent during World War I. Today, people are exposed at home or during industrial accidents. Exposure at home can occur while chlorinating a pool or swimming. Chlorine gas is also produced when bleach containing hypochlorite is mixed with an acid. Industrial uses include water purification, textile and paper bleaching, chemical and plastic manufacturing, and disinfection.18

Chlorine gas directly damages the respiratory mucosa when it combines with water to form hypochlorous and hydrochloric acids (see below). Free radicals are formed which propagate an inflammatory response, leading to neutrophil recruitment and cytokine release. Epithelial cell necrosis and increased pulmonary microvascular permeability have been demonstrated in animal models.26

Chlorine:

Cl2 + H2O → HCl + HOCl

The end result is edema and hemorrhage of the respiratory tract, with bronchiolar mucosal destruction and formation of exudate-filled alveoli. These responses predispose the respiratory tract to bacterial superinfection and ALI. Patients present with inflammation of the conjunctivae and upper respiratory tract, ALI, and respiratory failure. They develop bronchospasm, rales, a sore throat, cough, tachycardia, tachypnea, and hypoxia. Tachycardia is a result of pain, coughing, and hypoxia.

The value of nebulized sodium bicarbonate (NSB) to neutralize hydrochloric acid is debatable,9 but this therapeutic intervention likely has no adverse effects.25 The use of NSB is based on the assumption that there is a benefit from neutralization of the acids formed after chlorine exposure.15,27 The solution for nebulization is prepared by mixing 2 mL of 7.5% sodium bicarbonate with 2 mL of normal saline,15 or 3 mL of 8.4% sodium bicarbonate with 2 mL of normal saline.27

Little data on the use of NSB exist. There are case reports describing rapid and successful improvement in patients after a single NSB treatment.1415 No adverse events were reported in a retrospective review of poison center data involving 86 patients treated with NSB.27 Only 17 of the 86 patients required hospital admission. Among the admitted patients, mean hospital length of stay was 1.4 days. The timing and number of treatments and other adjunctive therapies varied among patients. Although unable to prove its efficacy, the authors concluded that NSB was potentially beneficial.27 A double-blind study of ED patients concluded that NSB was useful for treating patients with reactive airway dysfunction syndrome (RADS) secondary to chlorine gas exposure.28 Forty-four patients with RADS who were treated with corticosteroids and β2-agonists were pseudorandomized to receive either NSB or a nebulized placebo. Patients were placed in either the control or treatment group based on an even/odd presentation system (patients numbered 1, 3, 5, etc. were placed into one group, while patients 2, 4, 6, etc. were placed in the other group). To be diagnosed with RADS in this series, patients without preceding disease had to develop pulmonary complaints within 24 hours of a single exposure and have symptoms persist for at least 3 months. The patients who received NSB had significantly higher FEV1 values.28

Low Water Solubility

Phosgene

Phosgene (COCl2 or carbonyl chloride) is a colorless gas that is more dense than air.29 It was used as a chemical agent during World War I. Today, exposures occur during the synthesis of plastics and industrial materials, from decomposition of chlorinated hydrocarbons, or during the accidental heating of chlorofluorocarbons. The global consumption of phosgene was 5 million metric tons in 2006.30 Concentrations above 500 ppm/min are associated with fatalities.31

Phosgene’s odor has been described as similar to that of freshly mown hay. Even with its low odor threshold of 0.4 to 1.5 ppm, people may not remove themselves from an exposure because of its pleasant smell and/or development of olfactory fatigue.31 These factors combined with its minimal acute irritant effects cause people to suffer prolonged exposures, permitting the gas to enter the lower airways and leading to development of ALI, since dose determines degree of damage.31

Phosgene damages the respiratory tract by denaturing proteins and irreversibly disrupting the structure of cellular membranes.31 It also promotes depletion of glutathione and other endogenous antioxidants.3031 Phosgene forms hydrochloric acid (HCl) when it reacts with water in mucous membranes.29 These pathophysiologic effects result in pulmonary edema and hypoxia.32

Symptoms may initially include minor upper respiratory tract irritation. Patients then enter a latent phase and may improve clinically but still have ongoing biochemical injury. This latent phase can last hours; its duration is inversely proportional to the inhaled dose.31 The latent period is followed by ALI and pulmonary edema.31 The smell of gas or irritative effects have no prognostic significance,29,31 so cases of only moderate exposure to phosgene warrant further observation. Patients with a normal chest x-ray and without any signs or symptoms can be discharged after 8 hours of observation.31 Admitted patients who require endotracheal intubation should be treated with a protective ventilation strategy.32

Multiple treatment strategies target the reduction of inflammation produced by phosgene.31 N-acetylcysteine (NAC), aminophylline, isoproterenol, ibuprofen, and corticosteroids have all been studied in animal models.3337 Sciuto et al. tested multiple interventions after exposing rabbits and mice to phosgene.34 The rabbit model demonstrated improvement in multiple variables including decreased intratracheal pressure, increased cyclic adenosine monophosphate (cAMP) concentration in the lung tissue and decreased leukotriene formation after receiving aminophylline and intratracheal instillation of NAC and isoproterenol. The 12-hour survival rate was improved in mice exposed to phosgene after treatment with intraperitoneal ibuprofen, although survival at 24 hours was not affected.34 Others suggest that NAC ameliorates injury by helping to avoid depletion of glutathione.3536 In a rabbit model, corticosteroids given 1 hour before exposure to phosgene prevented damage from leukotrienes and other lipoxygenase derived products. Survival was not studied.33 In a porcine model, treatment with intravenous (IV) methylprednisolone or inhaled budesonide after exposure to phosgene failed to decrease mortality at 24 hours.37 Borak and Diller suggested treating patients with methylprednisolone (250 mg IV) or NAC (20 mL of a 20% nebulized solution).31

Asphyxiants

Inhaled asphyxiants are categorized as either simple or chemical. Simple asphyxiants cause hypoxia by displacing oxygen, thereby decreasing the amount of oxygen reaching the lungs. Common simple asphyxiants include carbon dioxide, methane, nitrogen, hydrogen, and helium.

Chemical asphyxiants disrupt the body’s ability to use oxygen by reducing hemoglobin’s ability to transport oxygen and/or disrupting the electron transport chain in mitochondria, leading to impaired aerobic respiration and adenosine triphosphate (ATP) formation. Carbon monoxide (CO), cyanide (CN), and hydrogen sulfide (H2S) are chemical asphyxiants.

Carbon Monoxide

CO is a colorless, odorless gas produced from the incomplete combustion of carbon-containing fuels.38 Common sources of carbon monoxide include house fires, smoke inhalation, automobile exhaust, indoor heating systems and water heaters, forklifts, electric generators, and Zambonis. CO exposure is the leading cause of mortality from poisoning in the United States, accounting for an estimated 40,000 emergency department visits and 800 to 6000 deaths per year.3940 These numbers may be underestimates because of the nonspecific signs and symptoms of CO poisoning.41

CO binds hemoglobin, forming carboxyhemoglobin, with an affinity 200 times greater than that of oxygen.38,40,4244 The high affinity of CO for hemoglobin interferes with the ability of hemoglobin to bind oxygen and also shifts the oxygen dissociation curve to the left, preventing release of oxygen from hemoglobin in tissues.43,4547 CO also binds to other heme-containing proteins.4445 CO also disrupts the electron transport chain by binding to cytochrome aa3.47 By binding to myoglobin,44 CO reduces oxygen availability in cardiac tissue.40 CO also increases nitric oxide levels, causing vasodilatation which results in syncope.40,47 Neurologic injury may be the result of reperfusion injury to the hypoxic tissue.46

CO is called the “great imitator,” because patients present with nonspecific signs and symptoms including headache, fatigue, malaise, and influenza-like and gastroenteritis-like symptoms.43 The brain and heart have higher oxygen requirements and are more severely affected by CO-induced cellular hypoxia46; patients develop electrocardiographic (ECG) changes, chest pain, myocardial infarction,43 syncope, and neurologic deficits.40 Neurologic sequelae are divided into persistent neurologic sequelae (PNS) and delayed neurologic sequelae (DNS).44 PNS occur at the time of exposure, whereas DNS begin 2 to 40 days after exposure. Fear of these sequelae is the rationale behind hyperbaric oxygen therapy (HBO).

PNS and DNS share the same psychoneurologic symptoms,48 including aphasia, apraxia, apathy, disorientation, hallucinations, bradykinesia, rigidity, gait disturbances, and personality changes.47 The incidence of DNS is unknown for two primary reasons: lack of a consistent definition42 and lack of validated neuropsychometric tests to screen for presence of the syndrome.40 Current research is focused on finding biomarkers to assess risk for DNS.49

Samples of either venous or arterial blood can be used to measure CO levels, because they correlate well in prospective studies.4041 A level greater than 2% in nonsmokers or 9% in smokers suggests exposure to exogenous CO.39,41 Because patients are removed from the exposure and/or receive oxygen prior to the level being obtained, levels may be “falsely” low. Carboxyhemoglobin levels do not correlate well with the patient’s clinical presentation or degree of injury, particularly at higher levels.41,44,47 Patients exposed to CO can have lactic acidosis.40 Pulse oximeters report falsely elevated hemoglobin saturations, as these devices fail to differentiate between oxygenated hemoglobin and carboxyhemoglobin. Conversely, co-oximetry differentiates between oxyhemoglobin and carboxyhemoglobin. Newer handheld oximetry probes accurately detect carboxyhemoglobin. Low-density bilateral globus pallidus lesions have been reported on head computed tomography (CT). These lesions, which may resolve with time, often develop within a few hours after the injury,47 but their appearance can be delayed for days.40

Placing patients on 100% oxygen lowers the half-life of carboxyhemoglobin from 240 minutes on room air to 80 minutes. Hyperbaric oxygen (HBO) lowers the half-life to approximately 20 minutes.40

The use of HBO is controversial.44,50 Four prospective randomized trials have evaluated its use.48,5052 The studies differed with respect to inclusion criteria, outcomes, definition of DNS, and HBO protocols. Of the four, the Weaver et al.48 and Scheinkestel et al.50 studies were the only ones that were blinded via the use of sham HBO (chamber was turned “on” and made noise but was not pressurized). The Weaver study is the most methodologically rigorous and well controlled of all the trials but is not above criticism40; it included patients with documented exposure to CO and also symptomatic patients thought to be exposed to CO.48 Patients underwent three treatments within 24 hours; the first at 3 atmospheres absolute (ATA) and the others at 2 ATA. Pregnant patients, patients younger than 16 years of age, moribund patients, and anyone more than 24 hours from exposure were excluded. Weaver et al. concluded that HBO decreased the frequency of cognitive sequelae at 6 weeks and 12 months. The number needed to treat was 5 at 6 weeks.48 In the Scheinkestel study, the hyperbaric group received HBO once daily at 2.8 ATA for 60 minutes for 3 to 6 days.50 Except for children and pregnant women, any patient with CO poisoning, regardless of the severity or time since exposure, was included. Patients were assessed with many neuropsychiatric tests at the completion of hyperbaric treatment and 1 month later. All five cases of DNS occurred in the group that received HBO. Also, the normobaric group had fewer abnormal neuropsychiatric tests at the completion of therapy. The authors concluded that HBO did not offer a benefit and may have worsened some outcomes. However, only 46% of patients were followed up at 1 month, weakening the conclusions from this study.50 Conversely, there was a 97% follow-up rate in the study by Weaver and coworkers.48

Two other trials were randomized but not blinded.5152 Raphael et al.52 included 629 patients with accidental inhalation of CO who presented within 12 hours of exposure. Pregnant women were excluded. Patients were stratified on the basis of absence or presence of loss of consciousness (LOC), and treatment groups received one or two treatments with HBO. Follow up at 1 month was carried out using a self-assessment questionnaire. Raphael et al.52 concluded that HBO might offer some benefit in patients with LOC, but not in patients without LOC. The study by Thom and colleagues51 enrolled 60 patients who presented within 6 hours of exposure to CO. The subjects were randomized to receive either one session of HBO or normobaric oxygen. Patients with LOC or EKG changes were excluded. Patients receiving HBO had a lower incidence of DNS determined by testing immediately afterwards and at 1 month.51

Although controversy exists regarding the indications for HBO, we suggest using the enrollment criteria from the study by Weaver et al.,48 because this study’s methods improved outcomes. Indications, therefore, include neurologic findings (altered mental status, coma, focal deficits, seizures), syncope, pregnancy with carboxyhemoglobin concentration above 15%, cardiovascular compromise (ischemia, infarction, dysrhythmia), metabolic acidosis, concentrations greater than 25% in nonpregnant patients, and extremes of age.40 The only absolute contraindication is untreated pneumothorax, but relative contraindications include chronic obstructive pulmonary disease, fever, bowel obstruction, and significant upper respiratory tract infection.40,53

The most common complication of HBO therapy is barotrauma; however, oxygen toxicity and seizures also have been reported.40,48,50,53 While in the HBO chamber, the patient cannot receive defibrillation or electrical cardioversion. Also, the treatment team has limited access to the patient. Therefore some patients may be too unstable for HBO. In some cases, logistical challenges or the patient’s underlying instability may render the situation so dangerous or so complex that transport to a facility that offers HBO is unfeasible.

Cyanide

Cyanide is one of the most rapidly acting and lethal poisons in existence.54 Its infamy stems from its use in mass killing by the Nazis during World War II and the mass suicide led by Jim Jones in the 1970s. Other sources of cyanide include food (pits of members of the genus Prunus), photographic developer solutions, electroplating solutions, rodenticides, artificial nail remover, and sodium nitroprusside metabolism. Inhalation of smoke from structural fires is the most common source of cyanide exposure in the United States and Western countries.5556 Hydrogen cyanide formation from the combustion of carbon- and nitrogen-based materials and abundant plastics, polymers, synthetic fibers, and wools in houses are major contributors.5455 Cyanide toxicity also should be suspected in the sudden collapse of a laboratory or industrial worker or an unexplained coma or severe acidosis following a suicide attempt.57 The clinical effects of cyanide poisoning depend on the dose, duration, and route of exposure.58

Cyanide binds to the ferric iron portion of cytochrome oxidase and inhibits it at the cytochrome a3 portion of the mitochondrial electron transport chain.8,54,5859 Binding of cyanide to cytochrome oxidase prevents mitochondria from using oxygen, thereby inhibiting aerobic metabolism.5556 Clinical manifestations reflect the failure of aerobic respiration.58 The CNS and heart have high demands for oxygen and are the most susceptible organs to cyanide poisoning.54 Transient increases in blood pressure, respiratory rate, and heart rate are followed by respiratory depression without cyanosis and cardiovascular collapse.55 Patients may present with syncope, dilated pupils, or seizures.59 Other presentations include headache, confusion, lethargy, agitation, and pulmonary edema. Unmetabolized cyanide has a bitter-almond-like odor and is excreted during breathing. However, 50% of the population cannot detect the odor.55,58

Hallmark laboratory findings include metabolic acidosis with elevated circulating lactate concentration.55 In smoke inhalation victims, blood lactate concentration above 10 mmol/L suggests cyanide toxicity.60 In victims of cyanide poisoning, the oxygen content of venous blood is abnormally high due to inhibition of cellular oxygen utilization.55,58 The arteriovenous oxygen saturation difference may be less than 10 mmHg, and “arterialization” of venous and capillary blood is responsible for the characteristic cherry-red complexion and bright red retinal veins seen on examination of cyanide poisoning victims.55,58 Cyanide is an unstable molecule with a short half-life, and blood levels usually are not available from the laboratory in a timely enough fashion to be clinically useful.59 As such, the diagnosis is difficult to make and requires a high level of suspicion.61

There are two specific cyanide treatments available in the United States.54 The traditional kit available from Eli Lilly and Company contains amyl nitrite, sodium nitrite, and sodium thiosulfate. Amyl nitrite ampules are inhaled to produce a methemoglobinemia. Once IV access is established, sodium nitrite (300 mg) is given IV to induce a methemoglobinemia (methemoglobin concentration = 20%-30%). Cyanide preferentially binds to methemoglobin over hemoglobin, forming cyanomethemoglobin.62 Administration of nitrites can be detrimental, however, because of the complications associated with methemoglobinemia.54 These complications include dyspnea, hypotension, acidosis, tachycardia, tachypnea, syncope, and CNS depression. Methemoglobinemia is a problem for patients who have been in a fire, as they may already have a significant carboxyhemoglobinemia54,56; thus, deliberate induction of methemoglobinemia results in two hemoglobinopathies at once.61 Sodium thiosulfate acts as a substrate to convert cyanide to thiocyanate but has a comparatively delayed onset of action.63 Adult dosing is 12.5 grams IV as a bolus or over half an hour.

Hydroxocobalamin is a precursor of vitamin B12 and binds to cyanide to form cyanocobalamin (vitamin B12), which is then renally excreted.61 Unlike the case with nitrites, hydroxocobalamin has few side effects. It is associated with temporary skin discoloration that can interfere with the accuracy of co-oximetry. A recent review recommends hydroxocobalamin (5 g IV) for empirical treatment of smoke inhalation victims suspected of having cyanide toxicity.61

Hydrogen Sulfide

Hydrogen sulfide is a colorless gas with a characteristic “rotten egg” odor.64 It is a byproduct of human and animal waste and produced by the decay of organic material.65 Its mechanism of toxicity is through competitive inhibition of the electron transport chain,6668 but it also is an irritant.65, 69

Hydrogen sulfide’s odor is perceived at levels of 3 to 30 ppm,65 with olfactory paralysis occurring at 100 to 150 ppm.6667 Patients present with complaints including headache, weakness, incoordination, cough, dyspnea, and gastrointestinal symptoms.66 Cyanosis, pulmonary edema, cardiac dysrhythmias, and keratoconjunctivitis are present on examination.66 If an exposed patient has coins (e.g., dimes or quarters) in his or her pockets during the period when hydrogen sulfide is present in the atmosphere, the coins undergo reaction with the gas and turn black.67 Diagnosis is based on history, because a clinically useful laboratory test is not readily available.

There may be a role for nitrites and HBO in the treatment of hydrogen sulfide toxicity. The nitrite-induced methemoglobin has a high affinity for hydrogen sulfide and enables cytochrome oxidase to resume aerobic metabolism.65 Case reports refer to the use of HBO, as it may enhance detoxification of hydrogen sulfide.64,70 However, there is little supporting evidence for HBO, and its use cannot be recommended enthusiastically until further research is conducted.646568

Key Points

Annotated References

Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. 2002;347:1057-1067.

Three hyperbaric oxygen treatments within a 24-hour period, compared to a control, reduced the risk of cognitive sequelae 6 weeks and 12 months after acute carbon monoxide poisoning. This contrasts with the Scheinkestel study listed below.

Miller K, Chen A. Acute inhalation injury. Emerg Med Clin North Am. 2003;21:533-557.

The lungs can be an efficient means for the absorption of inhaled toxicants, resulting in airway and pulmonary injury or systemic toxicity. Although few specific antidotes exist for inhaled toxicants, the syndrome of acute inhalational injury and clinical therapeutics is linked by common pathways of pathophysiology.

Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med. 2007;49:806-813.

Based on recent safety and efficacy studies in animals, safety studies in healthy volunteers, and uncontrolled efficacy studies in humans, hydroxocobalamin seems to be an appropriate antidote for empirical treatment of smoke inhalation and other suspected cyanide poisoning for victims in the out-of-hospital setting.

Aslan S, Kandis H, Akgun M, et al. The effect of nebulized NaHCO3 treatment on “RADS” due to chlorine gas inhalation. Inhal Toxicol. 2006;18:895-900.

Nebulized sodium bicarbonate has beneficial short-term effects, as measured by PFTs and quality-of-life score, in patients with RADS secondary to chlorine gas exposure.

Sjöblom E, Höjer J, Kulling PEJ, et al. A placebo-controlled experimental study of steroid inhalation therapy in ammonia-induced lung injury. J Toxicol Clin Toxicol. 1999;37:59-67.

The major findings in this study were that inhalation of corticosteroids did not improve gas exchange or reduce the airway pressure levels compared to placebo in this animal model.

Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomized controlled clinical trial. Med J Aust. 1999;170:203-210.

One hyperbaric treatment daily for 3 to 6 days, compared to a control, found no benefit and possible adverse effects. This is in contrast to the Weaver study noted above.

References

1 Chow C-W, Moraes T, Dwoney G. Albert: Clinical Respiratory Medicine, 3rd ed. Philadelphia: Elsevier; 2008.

2 Suil K, Shao M, Nadel J. Mason: Murry and Nadel’s Textbook of Respiratory Medicine, 4th ed. Philadelphia: Elsevier; 2005.

3 Miller K, Chang A. Acute inhalation injury. Emerg Med Clin North Am. May 2003;21(2):533-557.

4 Rabinowitz PM, Siegel MD. Acute inhalation injury. Clin Chest Med. Dec 2002;23(4):707-715.

5 Kales SN, Christiani DC. Acute chemical emergencies. N Engl J Med. Feb 19 2004;350(8):800-808.

6 Welch A. Exposing the dangers of anhydrous ammonia. Nurse Pract. Nov 2006;31(11):40-45.

7 Amshel CE, Fealk MH, Phillips BJ, Caruso DM. Anhydrous ammonia burns case report and review of the literature. Burns. Aug 2000;26(5):493-497.

8 White CE, Park MS, Renz EM, et al. Burn center treatment of patients with severe anhydrous ammonia injury: case reports and literature review. J Burn Care Res. Nov-Dec 2007;28(6):922-928.

9 Van Sickle D, Wenck MA, Belflower A, et al. Acute health effects after exposure to chlorine gas released after a train derailment. Am J Emerg Med. Jan 2009;27(1):1-7.

10 Pirjavec A, Kovic I, Lulic I, Zupan Z. Massive anhydrous ammonia injury leading to lung transplantation. J Trauma. Oct 2009;67(4):E93-E97.

11 Bloom GR, Suhail F, Hopkins-Price P, Sood A. Acute anhydrous ammonia injury from accidents during illicit methamphetamine production. Burns. Aug 2008;34(5):713-718.

12 Sjoblom E, Hojer J, Kulling PE, Stauffer K, Suneson A, Ludwigs U. A placebo-controlled experimental study of steroid inhalation therapy in ammonia-induced lung injury. J Toxicol Clin Toxicol. 1999;37(1):59-67.

13 Chester EH, Kaimal J, Payne CBJr, Kohn PM. Pulmonary injury following exposure to chlorine gas. Possible beneficial effects of steroid treatment. Chest. Aug 1977;72(2):247-250.

14 Douidar SM. Nebulized sodium bicarbonate in acute chlorine inhalation. Pediatr Emerg Care. Dec 1997;13(6):406-407.

15 Vinsel PJ. Treatment of acute chlorine gas inhalation with nebulized sodium bicarbonate. J Emerg Med. May-Jun 1990;8(3):327-329.

16 O’Kane GJ. Inhalation of ammonia vapour. A report on the management of eight patients during the acute stages. Anaesthesia. Dec 1983;38(12):1208-1213.

17 Winder C. The toxicology of chlorine. Environ Res. Feb 2001;85(2):105-114.

18 Babu RV, Cardenas V, Sharma G. Acute respiratory distress syndrome from chlorine inhalation during a swimming pool accident: a case report and review of the literature. J Intensive Care Med. Jul-Aug 2008;23(4):275-280.

19 Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest. Apr 2007;131(4):954-963.

20 Steinberg KP, Hudson LD, Goodman RB, et al. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med. Apr 20 2006;354(16):1671-1684.

21 Makarovsky I, Markel G, Dushnitsky T, Eisenkraft A. Ammonia—when something smells wrong. Isr Med Assoc J. Jul 2008;10(7):537-543.

22 Greenberg ML, Hamilton R, Phillips S, McClusky GJ. Occupational, industrial, and environmental toxicology, 2nd ed. St. Louis: Mosby; 2003.

23 Darchy B, Le Miere E, Lacour S, Bavoux E, Domart Y. Acute ammonia inhalation. Intensive Care Med. May 1997;23(5):597-598.

24 Close LG, Catlin FI, Cohn AM. Acute and chronic effects of ammonia burns on the respiratory tract. Arch Otolaryngol. Mar 1980;106(3):151-158.

25 Sexton JD, Pronchik DJ. Chlorine inhalation: the big picture. J Toxicol Clin Toxicol. 1998;36(1-2):87-93.

26 Traub SJ, Hoffman RS, Nelson LS. Case report and literature review of chlorine gas toxicity. Vet Hum Toxicol. Aug 2002;44(4):235-239.

27 Bosse GM. Nebulized sodium bicarbonate in the treatment of chlorine gas inhalation. J Toxicol Clin Toxicol. 1994;32(3):233-241.

28 Aslan S, Kandis H, Akgun M, Cakir Z, Inandi T, Gorguner M. The effect of nebulized NaHCO3 treatment on “RADS” due to chlorine gas inhalation. Inhal Toxicol. Oct 2006;18(11):895-900.

29 Lim SC, Yang JY, Jang AS, et al. Acute lung injury after phosgene inhalation. Korean J Intern Med. Jan 1996;11(1):87-92.

30 Pauluhn J, Carson A, Costa DL, et al. Workshop summary: phosgene-induced pulmonary toxicity revisited: appraisal of early and late markers of pulmonary injury from animal models with emphasis on human significance. Inhal Toxicol. Aug 2007;19(10):789-810.

31 Borak J, Diller WF. Phosgene exposure: mechanisms of injury and treatment strategies. J Occup Environ Med. Feb 2001;43(2):110-119.

32 Parkhouse DA, Brown RF, Jugg BJ, et al. Protective ventilation strategies in the management of phosgene-induced acute lung injury. Mil Med. Mar 2007;172(3):295-300.

33 Guo YL, Kennedy TP, Michael JR, et al. Mechanism of phosgene-induced lung toxicity: role of arachidonate mediators. J Appl Physiol. Nov 1990;69(5):1615-1622.

34 Sciuto AM, Hurt HH. Therapeutic treatments of phosgene-induced lung injury. Inhal Toxicol. Jul 2004;16(8):565-580.

35 Sciuto AM, Strickland PT, Kennedy TP, Gurtner GH. Protective effects of N-acetylcysteine treatment after phosgene exposure in rabbits. Am J Respir Crit Care Med. Mar 1995;151(3 Pt 1):768-772.

36 Konukoglu D, Cetinkale O, Bulan R. Effects of N-acetylcysteine on lung glutathione levels in rats after burn injury. Burns. Nov-Dec 1997;23(7-8):541-544.

37 Smith A, Brown R, Jugg B, et al. The effect of steroid treatment with inhaled budesonide or intravenous methylprednisolone on phosgene-induced acute lung injury in a porcine model. Mil Med. Dec 2009;174(12):1287-1294.

38 Thom SR. Hyperbaric-oxygen therapy for acute carbon monoxide poisoning. N Engl J Med. Oct 3 2002;347(14):1105-1106.

39 Piantadosi CA. Carbon monoxide poisoning. N Engl J Med. Oct 3 2002;347(14):1054-1055.

40 Kao LW, Nanagas KA. Carbon monoxide poisoning. Emerg Med Clin North Am. Nov 2004;22(4):985-1018.

41 Hampson NB, Hauff NM. Carboxyhemoglobin levels in carbon monoxide poisoning: do they correlate with the clinical picture? Am J Emerg Med. Jul 2008;26(6):665-669.

42 Juurlink DN, Buckley NA, Stanbrook MB, Isbister GK, Bennett M, McGuigan MA. Hyperbaric oxygen for carbon monoxide poisoning. Cochrane Database Syst Rev 2005(1):CD002041.

43 Wu CT, Huang JL, Hsia SH. Acute carbon monoxide poisoning with severe cardiopulmonary compromise: a case report. Cases J. 2009;2(1):52.

44 Kealey GP. Carbon monoxide toxicity. J Burn Care Res. Jan-Feb 2009;30(1):146-147.

45 Silver DA, Cross M, Fox B, Paxton RM. Computed tomography of the brain in acute carbon monoxide poisoning. Clin Radiol. Jul 1996;51(7):480-483.

46 Townsend CL, Maynard RL. Effects on health of prolonged exposure to low concentrations of carbon monoxide. Occup Environ Med. Oct 2002;59(10):708-711.

47 Thom SR, Keim LW. Carbon monoxide poisoning: a review epidemiology, pathophysiology, clinical findings, and treatment options including hyperbaric oxygen therapy. J Toxicol Clin Toxicol. 1989;27(3):141-156.

48 Weaver LK, Hopkins RO, Chan KJ, et al. Hyperbaric oxygen for acute carbon monoxide poisoning. N Engl J Med. Oct 3 2002;347(14):1057-1067.

49 Thom SR, Bhopale VM, Milovanova TM, et al. Plasma biomarkers in carbon monoxide poisoning. Clin Toxicol (Phila). Jan 2010;48(1):47-56.

50 Scheinkestel CD, Bailey M, Myles PS, et al. Hyperbaric or normobaric oxygen for acute carbon monoxide poisoning: a randomised controlled clinical trial. Med J Aust. Mar 1 1999;170(5):203-210.

51 Thom SR, Taber RL, Mendiguren II, Clark JM, Hardy KR, Fisher AB. Delayed neuropsychologic sequelae after carbon monoxide poisoning: prevention by treatment with hyperbaric oxygen. Ann Emerg Med. Apr 1995;25(4):474-480.

52 Raphael JC, Elkharrat D, Jars-Guincestre MC, et al. Trial of normobaric and hyperbaric oxygen for acute carbon monoxide intoxication. Lancet. Aug 19 1989;2(8660):414-419.

53 Weiss LD, Van Meter KW. The applications of hyperbaric oxygen therapy in emergency medicine. Am J Emerg Med. Nov 1992;10(6):558-568.

54 Shepherd G, Velez LI. Role of hydroxocobalamin in acute cyanide poisoning. Ann Pharmacother. May 2008;42(5):661-669.

55 Borron SW. Recognition and treatment of acute cyanide poisoning. J Emerg Nurs. Aug 2006;32(4 Suppl):S12-S18.

56 Eckstein M. Enhancing public health preparedness for a terrorist attack involving cyanide. J Emerg Med. Jul 2008;35(1):59-65.

57 Flomenbaum NE, Goldfrank LR, Hoffman RS, Howland MA, Lewin NA, Nelson LS. Goldfrank’s toxicologic emergencies, 8th ed. New York: McGraw-Hill; 2002.

58 Nelson L. Acute cyanide toxicity: mechanisms and manifestations. J Emerg Nurs. Aug 2006;32(4 Suppl):S8-11.

59 Baud FJ. Cyanide: critical issues in diagnosis and treatment. Hum Exp Toxicol. Mar 2007;26(3):191-201.

60 Baud FJ, Barriot P, Toffis V, et al. Elevated blood cyanide concentrations in victims of smoke inhalation. N Engl J Med. Dec 19 1991;325(25):1761-1766.

61 Hall AH, Dart R, Bogdan G. Sodium thiosulfate or hydroxocobalamin for the empiric treatment of cyanide poisoning? Ann Emerg Med. Jun 2007;49(6):806-813.

62 Barillo DJ. Diagnosis and treatment of cyanide toxicity. J Burn Care Res. Jan-Feb 2009;30(1):148-152.

63 Silverman SH, Purdue GF, Hunt JL, Bost RO. Cyanide toxicity in burned patients. J Trauma. Feb 1988;28(2):171-176.

64 Yalamanchili C, Smith MD. Acute hydrogen sulfide toxicity due to sewer gas exposure. Am J Emerg Med. May 2008;26(4):518. e515-517

65 Gerasimon G, Bennett S, Musser J, Rinard J. Acute hydrogen sulfide poisoning in a dairy farmer. Clin Toxicol (Phila). May 2007;45(4):420-423.

66 Gunn B, Wong R. Noxious gas exposure in the outback: two cases of hydrogen sulfide toxicity. Emerg Med (Fremantle). Jun 2001;13(2):240-246.

67 Knight LD, Presnell SE. Death by sewer gas: case report of a double fatality and review of the literature. Am J Forensic Med Pathol. Jun 2005;26(2):181-185.

68 Smilkstein MJ, Bronstein AC, Pickett HM, Rumack BH. Hyperbaric oxygen therapy for severe hydrogen sulfide poisoning. J Emerg Med. 1985;3(1):27-30.

69 Milby TH, Baselt RC. Hydrogen sulfide poisoning: clarification of some controversial issues. Am J Ind Med. Feb 1999;35(2):192-195.

70 Hsu P, Li H-W, Lin Y-T. Acute hydrogen sulfide poisoning treated with hyperbaric oxygen. J Hyperb Med. 1987;2(4):215-221.